| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apnea | 10 | 2018 | 16 | 1.820 |
Why?
|
| Infant, Extremely Low Birth Weight | 4 | 2019 | 19 | 1.630 |
Why?
|
| Sudden Infant Death | 15 | 2018 | 36 | 1.590 |
Why?
|
| Infant, Premature | 20 | 2019 | 181 | 1.550 |
Why?
|
| Infant, Newborn | 38 | 2019 | 538 | 1.550 |
Why?
|
| Bradycardia | 9 | 2018 | 22 | 1.430 |
Why?
|
| Infant | 33 | 2021 | 488 | 1.090 |
Why?
|
| Sleep Apnea, Central | 4 | 2021 | 30 | 1.010 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2017 | 36 | 0.960 |
Why?
|
| Sleep Apnea Syndromes | 12 | 2005 | 26 | 0.900 |
Why?
|
| Developmental Disabilities | 2 | 2014 | 24 | 0.800 |
Why?
|
| Child Development | 10 | 2014 | 68 | 0.800 |
Why?
|
| Pediatrics | 1 | 2022 | 38 | 0.770 |
Why?
|
| Monitoring, Physiologic | 10 | 2005 | 68 | 0.750 |
Why?
|
| Medulla Oblongata | 1 | 2021 | 2 | 0.740 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 123 | 0.740 |
Why?
|
| Infant, Premature, Diseases | 2 | 2012 | 26 | 0.680 |
Why?
|
| Accidental Falls | 1 | 2021 | 105 | 0.670 |
Why?
|
| Humans | 66 | 2022 | 23541 | 0.660 |
Why?
|
| Hypoventilation | 11 | 2003 | 38 | 0.650 |
Why?
|
| Polysomnography | 7 | 2021 | 72 | 0.630 |
Why?
|
| Fetal Blood | 1 | 2019 | 11 | 0.630 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2019 | 5 | 0.620 |
Why?
|
| Home Nursing | 5 | 2005 | 32 | 0.610 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2019 | 15 | 0.610 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2019 | 28 | 0.600 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 605 | 0.580 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 908 | 0.540 |
Why?
|
| Enteral Nutrition | 1 | 2017 | 61 | 0.520 |
Why?
|
| Quality of Health Care | 1 | 2017 | 96 | 0.500 |
Why?
|
| Female | 43 | 2021 | 13239 | 0.490 |
Why?
|
| Central Nervous System | 2 | 2014 | 48 | 0.480 |
Why?
|
| Milk, Human | 1 | 2017 | 156 | 0.460 |
Why?
|
| Child | 21 | 2022 | 1178 | 0.450 |
Why?
|
| Hydrocortisone | 1 | 2014 | 38 | 0.440 |
Why?
|
| Infant, Very Low Birth Weight | 4 | 2014 | 153 | 0.440 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 72 | 0.420 |
Why?
|
| Motor Skills Disorders | 3 | 2012 | 14 | 0.410 |
Why?
|
| Male | 37 | 2019 | 12743 | 0.410 |
Why?
|
| Quality Improvement | 1 | 2014 | 128 | 0.400 |
Why?
|
| Language Development Disorders | 1 | 2012 | 16 | 0.370 |
Why?
|
| Patient Compliance | 3 | 2005 | 145 | 0.370 |
Why?
|
| Heart Rate | 8 | 2006 | 104 | 0.360 |
Why?
|
| Child, Preschool | 14 | 2018 | 583 | 0.360 |
Why?
|
| Respiration | 8 | 2006 | 29 | 0.350 |
Why?
|
| Risk Factors | 11 | 2017 | 1997 | 0.330 |
Why?
|
| Neuropsychological Tests | 2 | 2012 | 867 | 0.320 |
Why?
|
| Monitoring, Ambulatory | 1 | 2009 | 16 | 0.300 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 244 | 0.300 |
Why?
|
| Cognition Disorders | 1 | 2012 | 690 | 0.270 |
Why?
|
| Incidence | 6 | 2017 | 644 | 0.250 |
Why?
|
| Choanal Atresia | 1 | 2006 | 2 | 0.250 |
Why?
|
| Diseases in Twins | 1 | 2006 | 9 | 0.250 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2019 | 172 | 0.240 |
Why?
|
| Tracheostomy | 2 | 2021 | 21 | 0.220 |
Why?
|
| Infant Care | 3 | 2003 | 17 | 0.220 |
Why?
|
| Night Care | 1 | 2003 | 1 | 0.200 |
Why?
|
| Licensure | 1 | 2003 | 6 | 0.200 |
Why?
|
| Organizational Policy | 1 | 2003 | 13 | 0.200 |
Why?
|
| Long-Term Care | 2 | 2021 | 56 | 0.190 |
Why?
|
| Cohort Studies | 3 | 2014 | 1465 | 0.190 |
Why?
|
| Syndrome | 8 | 2003 | 72 | 0.190 |
Why?
|
| Interactive Ventilatory Support | 1 | 2021 | 2 | 0.190 |
Why?
|
| Patient Care Management | 1 | 2021 | 16 | 0.180 |
Why?
|
| Physical Stimulation | 5 | 2004 | 9 | 0.180 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2003 | 154 | 0.180 |
Why?
|
| Transcription Factors | 4 | 2006 | 149 | 0.180 |
Why?
|
| Ventilator Weaning | 1 | 2021 | 30 | 0.180 |
Why?
|
| Leukomalacia, Periventricular | 4 | 2004 | 7 | 0.180 |
Why?
|
| United States | 4 | 2018 | 1837 | 0.180 |
Why?
|
| Sleep | 3 | 2018 | 270 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 4 | 2006 | 129 | 0.170 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 324 | 0.170 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2000 | 58 | 0.160 |
Why?
|
| Arousal | 4 | 2004 | 48 | 0.160 |
Why?
|
| Adolescent | 9 | 2018 | 1952 | 0.150 |
Why?
|
| Mass Media | 1 | 2018 | 10 | 0.150 |
Why?
|
| Cause of Death | 1 | 2018 | 58 | 0.140 |
Why?
|
| Mortality | 1 | 2018 | 74 | 0.140 |
Why?
|
| Homeodomain Proteins | 4 | 2006 | 55 | 0.140 |
Why?
|
| Intubation, Intratracheal | 1 | 2019 | 87 | 0.140 |
Why?
|
| Cocaine | 3 | 1994 | 31 | 0.140 |
Why?
|
| Respiration Disorders | 2 | 2001 | 4 | 0.140 |
Why?
|
| Histamine H2 Antagonists | 1 | 2017 | 6 | 0.140 |
Why?
|
| Protective Factors | 1 | 2017 | 20 | 0.140 |
Why?
|
| Anemia | 1 | 2017 | 30 | 0.140 |
Why?
|
| Probiotics | 1 | 2017 | 15 | 0.130 |
Why?
|
| Blood Transfusion | 1 | 2017 | 58 | 0.130 |
Why?
|
| Tissue and Organ Procurement | 1 | 2017 | 30 | 0.130 |
Why?
|
| Autonomic Nervous System | 3 | 2006 | 19 | 0.130 |
Why?
|
| Respiration, Artificial | 3 | 2004 | 102 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2018 | 118 | 0.130 |
Why?
|
| Patient Discharge | 1 | 2018 | 146 | 0.130 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 1492 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2014 | 3122 | 0.130 |
Why?
|
| Diaphragm | 2 | 1996 | 8 | 0.130 |
Why?
|
| Clinical Protocols | 3 | 2014 | 55 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 819 | 0.120 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1995 | 5 | 0.120 |
Why?
|
| Case-Control Studies | 8 | 2006 | 505 | 0.120 |
Why?
|
| Hemodynamics | 1 | 1995 | 62 | 0.120 |
Why?
|
| Exercise | 2 | 1997 | 400 | 0.120 |
Why?
|
| Electrocardiography | 3 | 2006 | 93 | 0.120 |
Why?
|
| Neurologic Examination | 2 | 2014 | 84 | 0.120 |
Why?
|
| Logistic Models | 2 | 2014 | 357 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 366 | 0.110 |
Why?
|
| Program Development | 1 | 2014 | 49 | 0.110 |
Why?
|
| Language Development | 1 | 2014 | 12 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2014 | 220 | 0.100 |
Why?
|
| Membrane Transport Proteins | 2 | 2003 | 38 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 50 | 0.100 |
Why?
|
| Autonomic Nervous System Diseases | 3 | 2002 | 24 | 0.100 |
Why?
|
| Cardiography, Impedance | 1 | 1992 | 2 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2003 | 88 | 0.100 |
Why?
|
| Psychomotor Performance | 2 | 2004 | 155 | 0.100 |
Why?
|
| Motor Activity | 1 | 2014 | 275 | 0.090 |
Why?
|
| Cerebral Ventricles | 2 | 2004 | 17 | 0.090 |
Why?
|
| Intelligence | 1 | 1992 | 14 | 0.090 |
Why?
|
| Psychometrics | 1 | 2012 | 177 | 0.090 |
Why?
|
| Nervous System Malformations | 2 | 2001 | 3 | 0.090 |
Why?
|
| Oximetry | 3 | 2004 | 10 | 0.090 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 1991 | 1 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 2 | 2004 | 104 | 0.090 |
Why?
|
| Obesity | 1 | 1993 | 294 | 0.080 |
Why?
|
| Linear Models | 2 | 2005 | 194 | 0.080 |
Why?
|
| Touch | 2 | 2002 | 8 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 1991 | 89 | 0.080 |
Why?
|
| Mutation | 4 | 2006 | 330 | 0.080 |
Why?
|
| Wakefulness | 2 | 2006 | 68 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2005 | 603 | 0.070 |
Why?
|
| Sleep Stages | 2 | 2004 | 19 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2004 | 47 | 0.070 |
Why?
|
| Genotype | 5 | 2006 | 248 | 0.070 |
Why?
|
| Rett Syndrome | 1 | 2006 | 5 | 0.060 |
Why?
|
| Dermatoglyphics | 1 | 2006 | 2 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2003 | 84 | 0.060 |
Why?
|
| Posture | 2 | 2003 | 57 | 0.060 |
Why?
|
| Twins, Monozygotic | 1 | 2006 | 8 | 0.060 |
Why?
|
| Facies | 1 | 2005 | 2 | 0.060 |
Why?
|
| Vestibule, Labyrinth | 2 | 2004 | 3 | 0.060 |
Why?
|
| Photic Stimulation | 2 | 2004 | 22 | 0.060 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2006 | 29 | 0.060 |
Why?
|
| Acoustic Stimulation | 2 | 2004 | 47 | 0.060 |
Why?
|
| Sensory Thresholds | 2 | 2004 | 22 | 0.060 |
Why?
|
| Xanthines | 1 | 2005 | 1 | 0.060 |
Why?
|
| Respiratory System Agents | 1 | 2005 | 1 | 0.060 |
Why?
|
| Marital Status | 1 | 2005 | 10 | 0.060 |
Why?
|
| Length of Stay | 3 | 2002 | 305 | 0.060 |
Why?
|
| Mental Processes | 1 | 2004 | 15 | 0.060 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2004 | 7 | 0.060 |
Why?
|
| Respiratory Therapy | 1 | 2004 | 8 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 24 | 0.060 |
Why?
|
| Adult | 7 | 2006 | 7168 | 0.060 |
Why?
|
| Neonatal Nursing | 3 | 2004 | 17 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2006 | 3093 | 0.050 |
Why?
|
| Haplotypes | 1 | 2003 | 41 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2006 | 555 | 0.050 |
Why?
|
| Phenotype | 4 | 2006 | 260 | 0.050 |
Why?
|
| Parents | 1 | 2005 | 107 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2013 | 271 | 0.050 |
Why?
|
| Dopamine | 2 | 1994 | 78 | 0.050 |
Why?
|
| Risk Management | 1 | 2003 | 5 | 0.050 |
Why?
|
| Intensive Care, Neonatal | 2 | 2004 | 29 | 0.050 |
Why?
|
| Urban Health Services | 1 | 2003 | 12 | 0.050 |
Why?
|
| Education | 1 | 2003 | 31 | 0.050 |
Why?
|
| Prone Position | 1 | 2003 | 26 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 2 | 2000 | 16 | 0.050 |
Why?
|
| Risk Reduction Behavior | 1 | 2003 | 36 | 0.050 |
Why?
|
| Infant Mortality | 2 | 2018 | 8 | 0.050 |
Why?
|
| Smoking | 1 | 2003 | 168 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2002 | 69 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2002 | 35 | 0.050 |
Why?
|
| Gestational Age | 3 | 2013 | 73 | 0.050 |
Why?
|
| Reference Values | 1 | 2002 | 168 | 0.050 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2002 | 64 | 0.050 |
Why?
|
| Birth Injuries | 1 | 2001 | 1 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 1999 | 234 | 0.040 |
Why?
|
| Mothers | 1 | 2003 | 160 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2000 | 10 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 778 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2000 | 33 | 0.040 |
Why?
|
| Anesthesia | 1 | 2000 | 28 | 0.040 |
Why?
|
| Chicago | 2 | 2018 | 818 | 0.040 |
Why?
|
| Pediatric Nursing | 1 | 1999 | 9 | 0.040 |
Why?
|
| Child Mortality | 1 | 2018 | 4 | 0.040 |
Why?
|
| Time Factors | 3 | 2004 | 1293 | 0.040 |
Why?
|
| Equipment Failure | 2 | 1996 | 35 | 0.040 |
Why?
|
| Students, Nursing | 1 | 1999 | 49 | 0.040 |
Why?
|
| Phrenic Nerve | 1 | 1996 | 2 | 0.030 |
Why?
|
| Endothelins | 1 | 1996 | 2 | 0.030 |
Why?
|
| Quadriplegia | 1 | 1996 | 8 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 1996 | 4 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1996 | 6 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 1996 | 22 | 0.030 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 1996 | 2 | 0.030 |
Why?
|
| Respiratory System | 1 | 1996 | 8 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1996 | 33 | 0.030 |
Why?
|
| Electroencephalography | 3 | 2004 | 78 | 0.030 |
Why?
|
| Hirschsprung Disease | 3 | 2006 | 10 | 0.030 |
Why?
|
| Maternal Age | 1 | 1995 | 13 | 0.030 |
Why?
|
| Minisatellite Repeats | 2 | 2006 | 7 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 1995 | 126 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 1050 | 0.030 |
Why?
|
| Coloboma | 1 | 1994 | 1 | 0.030 |
Why?
|
| Orofaciodigital Syndromes | 1 | 1994 | 1 | 0.030 |
Why?
|
| Retina | 1 | 1994 | 8 | 0.030 |
Why?
|
| Educational Status | 1 | 1995 | 214 | 0.030 |
Why?
|
| Plethysmography | 2 | 2006 | 3 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1994 | 6 | 0.030 |
Why?
|
| Neostriatum | 1 | 1994 | 13 | 0.030 |
Why?
|
| Hypoxia | 1 | 1994 | 30 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 1994 | 33 | 0.030 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1993 | 7 | 0.030 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1993 | 6 | 0.030 |
Why?
|
| Surveys and Questionnaires | 4 | 2003 | 1045 | 0.030 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2003 | 11 | 0.030 |
Why?
|
| Child Behavior | 1 | 1993 | 28 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2003 | 51 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2003 | 41 | 0.030 |
Why?
|
| DNA | 2 | 2003 | 95 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2013 | 42 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 1993 | 63 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 1745 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 1994 | 163 | 0.030 |
Why?
|
| Electric Stimulation Therapy | 1 | 1992 | 39 | 0.020 |
Why?
|
| Prognosis | 3 | 2001 | 749 | 0.020 |
Why?
|
| Equipment Design | 1 | 1992 | 122 | 0.020 |
Why?
|
| Prospective Studies | 1 | 1995 | 1532 | 0.020 |
Why?
|
| Observer Variation | 2 | 2002 | 88 | 0.020 |
Why?
|
| Narcotics | 1 | 1991 | 34 | 0.020 |
Why?
|
| Birth Weight | 2 | 1999 | 38 | 0.020 |
Why?
|
| Pregnancy | 3 | 1994 | 322 | 0.020 |
Why?
|
| Age Factors | 1 | 1990 | 648 | 0.020 |
Why?
|
| Pedigree | 2 | 2001 | 51 | 0.020 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2006 | 7 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 1996 | 4 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2006 | 13 | 0.020 |
Why?
|
| Fingers | 1 | 2006 | 8 | 0.020 |
Why?
|
| Infant Behavior | 2 | 1997 | 2 | 0.020 |
Why?
|
| Skin | 1 | 2006 | 119 | 0.020 |
Why?
|
| Sex Factors | 1 | 2006 | 393 | 0.010 |
Why?
|
| Breathing Exercises | 1 | 2004 | 3 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2004 | 28 | 0.010 |
Why?
|
| Terminal Care | 1 | 2004 | 23 | 0.010 |
Why?
|
| Malnutrition | 1 | 2004 | 22 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2004 | 43 | 0.010 |
Why?
|
| Scoliosis | 1 | 2004 | 34 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 10 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2003 | 10 | 0.010 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 2 | 1994 | 3 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 52 | 0.010 |
Why?
|
| Family Health | 1 | 2003 | 29 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2004 | 59 | 0.010 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2003 | 42 | 0.010 |
Why?
|
| Rabbits | 2 | 1994 | 165 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 125 | 0.010 |
Why?
|
| Beds | 1 | 2003 | 3 | 0.010 |
Why?
|
| Sleep Wake Disorders | 1 | 2004 | 111 | 0.010 |
Why?
|
| Peptides | 1 | 2003 | 89 | 0.010 |
Why?
|
| Videotape Recording | 1 | 2002 | 18 | 0.010 |
Why?
|
| Alleles | 1 | 2003 | 164 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2002 | 30 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1994 | 472 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 261 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 305 | 0.010 |
Why?
|
| Psychology, Child | 1 | 2002 | 5 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 48 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 106 | 0.010 |
Why?
|
| Health Promotion | 1 | 2003 | 139 | 0.010 |
Why?
|
| Cerebral Palsy | 1 | 2001 | 7 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 2001 | 13 | 0.010 |
Why?
|
| Airway Obstruction | 1 | 2001 | 18 | 0.010 |
Why?
|
| Mother-Child Relations | 1 | 2001 | 28 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2001 | 60 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2001 | 245 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 276 | 0.010 |
Why?
|
| Nervous System | 1 | 2000 | 9 | 0.010 |
Why?
|
| Hospitalization | 1 | 2002 | 292 | 0.010 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 1999 | 21 | 0.010 |
Why?
|
| Heart | 1 | 1998 | 59 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 443 | 0.010 |
Why?
|
| Survival Rate | 1 | 1998 | 323 | 0.010 |
Why?
|
| Aging | 1 | 2004 | 1101 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1996 | 4 | 0.010 |
Why?
|
| Karyotyping | 1 | 1996 | 11 | 0.010 |
Why?
|
| DNA Primers | 1 | 1996 | 49 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1996 | 49 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 1996 | 6 | 0.010 |
Why?
|
| Animals | 2 | 1994 | 3293 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 102 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 186 | 0.010 |
Why?
|
| Decision Trees | 1 | 1994 | 14 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1994 | 2 | 0.010 |
Why?
|
| Cues | 1 | 1994 | 36 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1994 | 17 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 1994 | 12 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 1994 | 87 | 0.010 |
Why?
|
| Clinical Nursing Research | 1 | 1993 | 3 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1993 | 30 | 0.010 |
Why?
|
| Panic Disorder | 1 | 1994 | 134 | 0.010 |
Why?
|
| Cerebellum | 1 | 1993 | 34 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 1993 | 46 | 0.010 |
Why?
|
| Comorbidity | 1 | 1994 | 431 | 0.010 |
Why?
|
| Apoptosis | 1 | 1993 | 198 | 0.010 |
Why?
|
| Growth | 1 | 1992 | 6 | 0.010 |
Why?
|
| Asthma | 1 | 1994 | 153 | 0.010 |
Why?
|